Amgen Inc.
AMGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $33 | $28 | $26 | $26 |
| % Growth | 18.6% | 7.1% | 1.3% | – |
| Cost of Goods Sold | $13 | $8 | $6 | $6 |
| Gross Profit | $21 | $20 | $20 | $20 |
| % Margin | 61.5% | 70.1% | 75.7% | 75.2% |
| R&D Expenses | $6 | $5 | $4 | $6 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $7 | $6 | $5 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $1 | $1 | $0 |
| Operating Expenses | $13 | $12 | $10 | $12 |
| Operating Income | $7 | $8 | $10 | $8 |
| % Margin | 21.7% | 28% | 36.3% | 29.4% |
| Other Income/Exp. Net | -$3 | -$0 | -$2 | -$1 |
| Pre-Tax Income | $5 | $8 | $7 | $7 |
| Tax Expense | $1 | $1 | $1 | $1 |
| Net Income | $4 | $7 | $7 | $6 |
| % Margin | 12.2% | 23.8% | 24.9% | 22.7% |
| EPS | 7.62 | 12.56 | 12.18 | 10.34 |
| % Growth | -39.3% | 3.1% | 17.8% | – |
| EPS Diluted | 7.56 | 12.49 | 12.11 | 10.28 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3 | $3 | $1 | $1 |
| Depreciation & Amortization | $6 | $4 | $3 | $3 |
| EBITDA | $13 | $15 | $12 | $11 |
| % Margin | 40% | 52.5% | 46.2% | 43.5% |